论文部分内容阅读
在美国和欧洲,每年都有关于天然产物供求方面的展览会,西安三江生物工程有限公司分别于2000年5月、10月参加了在美国新泽西和拉斯维加斯举办的国际贸易展示会。反馈信息表明,美国的原料药市场年需求量在40~60亿美元之间,包括矿物质、中草药、化学合成药等。中草药约占10亿美元的份额,其中美国本土生产的约5亿美元,从欧洲进口约2亿美元,从亚洲进口约2.5亿美元(包括中国、韩国、日本和印度),其中从中国进口约1亿美元。要想扩大我国在世界植物药市场的份额,国内各生产
In the United States and Europe, there are annual exhibitions on the supply and demand of natural products. Xi’an Sanjiang Bioengineering Co., Ltd. participated in the international trade exhibitions held in New Jersey and Las Vegas, USA in May and October 2000 respectively. The feedback shows that the annual demand of the API market in the United States is between 4 and 6 billion U.S. dollars, including minerals, Chinese herbal medicines, and chemical synthetic drugs. Chinese herbal medicines account for about 1 billion U.S. dollars, of which about 500 million U.S. dollars are domestically produced, about 200 million U.S. dollars are imported from Europe and about 250 million U.S. dollars are imported from Asia (including China, South Korea, Japan and India) 100 million US dollars. In order to expand our country’s share of the world’s plant medicine market, all domestic production